Last updated: October 10, 2024
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Gastric Cancer
Stomach Cancer
Adenocarcinoma
Treatment
mpMRI
Clinical Study ID
NCT06640153
2024-SR-587
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patients with gastric cancer confirmed by preoperative gastroscopic biopsy;
underwent standardized mpMRI and CT examination;
patients with complete postoperative pathological data and pathological results ofgastroesophageal Junction or upper gastric adenocarcinoma;
Exclusion
Exclusion Criteria:
combined with other tumors;
Clinical and imaging data were missing or could not meet the research needs;
the location of lesions could not be determined;
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: mpMRI
Phase:
Study Start date:
August 21, 2024
Estimated Completion Date:
August 24, 2027
Study Description
Connect with a study center
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.